FRANK E. THOMAS - 27 Feb 2026 Form 4 Insider Report for Larimar Therapeutics, Inc. (LRMR)

Role
Director
Signature
/s/ Jennifer Johansson, Attorney-in-fact
Issuer symbol
LRMR
Transactions as of
27 Feb 2026
Net transactions value
+$25,000
Form type
4
Filing time
02 Mar 2026, 16:30:36 UTC
Previous filing
16 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
THOMAS FRANK E Director C/O LARIMAR THERAPEUTICS, INC., THREE BALA PLAZA EAST, SUITE 506, BALA CYNWYD /s/ Jennifer Johansson, Attorney-in-fact 02 Mar 2026 0001242616

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LRMR Common Stock Purchase $25,000 +5,000 +250% $5.00 7,000 27 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock purchased in the underwritten offering of Larimar Therapeutics, Inc. at the offering price, which closed on February 27, 2026.